The neurologist at Cleveland Clinic Mellen MS Center spoke about the issues in multiple sclerosis that need to be addressed.
“I would say that still is the biggest unmet need which is effective treatments for progressive MS and to reverse tissue damage that's already occurred.”
Jeffrey Cohen, MD, a neurologist at the Cleveland Clinic Mellen Center sat down with NeurologyLive at the Americas Committee for Treatment and Research in Multiple Sclerosis in Dallas, Texas, to discuss areas in multiple sclerosis that need be addressed.
Cohen pointed out that the field is doing a good job of addressing main issues such as adding new therapies to the expansive repertoire of medications available for the early relapsing stage of the disease, however, more work still needs to be done.
There’s less progress being made when it comes to progressive disease, and comorbid conditions and health behaviors, however, these areas are starting to garner more attention.
Related Content:Americas Committee for Treatment and Research in Multiple Sclerosis | Conferences | News | Multiple Sclerosis